21
TITLE: Sialyl Lewis(X/A) and Cytokeratin Crosstalk in Triple Negative Breast Cancer
AUTHORS: Pascoal, Carlota; Carrascal, Mylene A.; Barreira, Daniela F.; Lourenco, Rita A.; Granjo, Pedro; Grosso, Ana R. R.; Borralho, Paula; Braga, Sofia; Videira, Paula A. A.;
PUBLISHED: 2023, SOURCE: CANCERS, VOLUME: 15, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 2 Handle
IN MY: ORCID
22
TITLE: Computational Approaches Drive Developments in Immune-Oncology Therapies for PD-1/PD-L1 Immune Checkpoint Inhibitors
AUTHORS: Sobral, Patricia S.; Luz, Vanessa C. C.; Almeida, Joao M. G. C. F.; Videira, Paula A.; Pereira, Florbela;
PUBLISHED: 2023, SOURCE: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, VOLUME: 24, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 5
IN MY: ORCID
23
TITLE: Congenital disorders of glycosylation (CDG): state of the art in 2022
AUTHORS: Francisco, Rita; Brasil, Sandra; Poejo, Joana; Jaeken, Jaak; Pascoal, Carlota; Videira, Paula A.; Ferreira, Vanessa dos Reis;
PUBLISHED: 2023, SOURCE: ORPHANET JOURNAL OF RARE DISEASES, VOLUME: 18, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 9
IN MY: ORCID
24
TITLE: Generation of Monocyte-Derived Dendritic Cells with Differing Sialylated Phenotypes
AUTHORS: Luz, Vanessa C. C.; Silva, Zelia; Sobral, Patricia; Tanwar, Ankit; Paterson, Rachel L.; Videira, Paula A.;
PUBLISHED: 2023, SOURCE: JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, VOLUME: 2023, ISSUE: 200
INDEXED IN: Scopus WOS CrossRef: 1
IN MY: ORCID
25
TITLE: A computer-aided drug design approach to discover tumour suppressor p53 protein activators for colorectal cancer therapy
AUTHORS: Patrício, RPS; Videira, PA; Pereira, F;
PUBLISHED: 2022, SOURCE: Bioorganic and Medicinal Chemistry, VOLUME: 53
INDEXED IN: Scopus CrossRef: 8
IN MY: ORCID
26
TITLE: The road to successful people-centric research in rare diseases: the web-based case study of the Immunology and Congenital Disorders of Glycosylation questionnaire (ImmunoCDGQ)
AUTHORS: Francisco, Rita; Brasil, Sandra; Pascoal, Carlota; Jaeken, Jaak; Liddle, Merell; Videira, Paula A.; Ferreira, Vanessa dos Reis;
PUBLISHED: 2022, SOURCE: ORPHANET JOURNAL OF RARE DISEASES, VOLUME: 17, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 3
IN MY: ORCID
27
TITLE: Registered human trials addressing environmental and occupational toxicant exposures: Scoping review of immunological markers and protective strategies
AUTHORS: Marques da Silva, Dorinda; Videira, Paula Alexandra; Lagoa, Ricardo;
PUBLISHED: 2022, SOURCE: ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, VOLUME: 93
INDEXED IN: Scopus WOS CrossRef: 4
IN MY: ORCID
28
TITLE: A Community-Led Approach as a Guide to Overcome Challenges for Therapy Research in Congenital Disorders of Glycosylation  Full Text
AUTHORS: Francisco, Rita; Brasil, Sandra; Pascoal, Carlota; Edmondson, Andrew C.; Jaeken, Jaak; Videira, Paula A.; de Freitas, Claudia ; Ferreira, Vanessa dos Reis; Marques da Silva, Dorinda;
PUBLISHED: 2022, SOURCE: INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, VOLUME: 19, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef: 1 Handle
IN MY: ORCID
29
TITLE: Editorial: Biomarkers in Genitourinary Cancers, Volume I
AUTHORS: Videira, Paula Alexandra; Borghesi, Marco; Singer, Eric A. A.;
PUBLISHED: 2022, SOURCE: FRONTIERS IN ONCOLOGY, VOLUME: 12
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
30
TITLE: Stakeholders' views on drug development: the congenital disorders of glycosylation community perspective
AUTHORS: Monticelli, Maria; Francisco, Rita; Brasil, Sandra; Marques da Silva, Dorinda; Rijoff, Tatiana; Pascoal, Carlota; Jaeken, Jaak; Videira, Paula A.; Ferreira, Vanessa dos Reis;
PUBLISHED: 2022, SOURCE: ORPHANET JOURNAL OF RARE DISEASES, VOLUME: 17, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 5
IN MY: ORCID
Page 3 of 12. Total results: 116.